Diabetes mellitus as risk factor for atrial fibrillation hospitalization: Incidence and outcomes over nine years in a region of Northern Italy-Reference-Cited by-同舟云学术

Diabetes mellitus as risk factor for atrial fibrillation hospitalization: Incidence and outcomes over nine years in a region of Northern Italy

Published:2015-09 Issue:3 Volume:109 Page:476-484
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Staszewsky Lidia^ORCID,Cortesi Laura,Baviera Marta,Tettamanti Mauro,Marzona Irene,Nobili Alessandro,Fortino Ida,Bortolotti Angela,Merlino Luca,Disertori Marcello,Latini Roberto,Roncaglioni Maria Carla

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference40 articles.

1. Global estimates of diabetes prevalence for 2013 and projections for 2035;Guariguata;Diabetes Res Clin Pract,2014

2. http://www.idf.org/sites/default/files/EN_6E_Atlas_Full_0.pdf.4.

3. http://www.epicentro.iss.it/igea/diabete/prevalenza.asp#ISTAT.

4. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study;Chugh;Circulation,2014

5. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060;Krijthe;Eur Heart J,2013

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of diabetes mellitus severity, treatment regimen and glycaemic control on atrial fibrillation prevalence in the Polish population aged ≥ 65;Scientific Reports;2023-10-12

2. Bioinformatics and functional experiments reveal that MRC2 inhibits atrial fibrillation via the PPAR signaling pathway;Journal of Thoracic Disease;2023-10

3. Impact of diabetes mellitus severity, treatment regimen and glycaemic control on atrial fibrillation prevalence. A report from the Non-invasive Monitoring for Early Detection of Atrial Fibrillation (NOMED-AF) prospective cross-sectional observational study;2023-01-30

4. Sodium–glucose cotransporter-2 inhibitor alleviated atrial remodeling in STZ-induced diabetic rats by targeting TLR4 pathway;Frontiers in Cardiovascular Medicine;2022-09-06

5. The complex interplay between diabetes mellitus and atrial fibrillation;Expert Review of Cardiovascular Therapy;2022-08-25